Table 1. Clinico-pathological features of 175 patientsa,b.
| Clinico-pathological factor | Classification | Tumour (no. of casesc) | BPHd (no. of casesc) |
|---|---|---|---|
| Gleason score | 2 | 2 | 2 |
| 4 | 2 | 3 | |
| 5 | 15 | 25 | |
| 6 | 30 | 34 | |
| 7 | 31 | 24 | |
| 8 | 36 | 21 | |
| 9 | 9 | 6 | |
| Subtotal | 125 | 115 | |
| pT-stage | pT2 | 55 | 84 |
| pT3 | 44 | 31 | |
| pT4 | 5 | 2 | |
| Subtotal | 109 | 113 | |
| Total | 131 | 126 |
BPH=benign prostatic hyperplasias.
a
Only cases evaluated are listed above. Both tumour material and BPH material could be analysed from 82 patients. Additionally, carcinoma was analysable in 49 cases and BPH in another 44 cases.
b
Age range 47–89 years, median 67, mean 66.
c
Clinico-pathological data were not available for all patients.
d
Benign prostatic hyperplasias adjacent to tumours with the denoted stage or Gleason score.